IP Verse

Axsome Therapeutics, Inc. V. Teva Pharmaceuticals, Inc. - 2:24-cv-06489

Explore the details of the Axsome Therapeutics, Inc. V. Teva Pharmaceuticals, Inc. case under case number 2:24-cv-06489 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:24-cv-06489
Filing Date
May 28, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
ANTECIP BIOVENTURES II LLC -
TEVA PHARMACEUTICALS, INC. -
AXSOME THERAPEUTICS, INC. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 23, 2024ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-6489 and 24-9535 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-6489 and that Civil Action No. 24-9535 shall be administratively terminated by the Clerk's office. The 9/27/2024 Letter Order setting the Initial Conference in Civil Action No. 24-6489 (ECF No. 18 ) shall control with respect to the Initial Disclosures, the Rule 26(f) Conference, submission of the Joint Discovery Plan, and the Initial Scheduling Conference for the Consolidated Actions. Signed by Magistrate Judge Leda D. Wettre on 10/23/2024. (wh) (Entered: 10/23/2024)PACER Document
Oct 29, 2024Corporate Disclosure Statement by TEVA PHARMACEUTICALS, INC.. (WALSH, LIZA) (Entered: 10/29/2024)PACER Document
Oct 29, 2024ANSWER to Complaint Teva's Answer to Complaint originally filed in Civil Action No. 24-9535, COUNTERCLAIM against ANTECIP BIOVENTURES II LLC, AXSOME THERAPEUTICS, INC. by TEVA PHARMACEUTICALS, INC..(WALSH, LIZA) (Entered: 10/29/2024)PACER Document
Nov 15, 2024Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs' time to answer, move, or otherwise reply to Defendant Teva Pharmaceuticals, Inc.'s Answer to Complaint, Affirmative Defenses, and Counterclaims (ECF No. 21).. (BATON, WILLIAM) (Entered: 11/15/2024)PACER Document
Dec 2, 2024Joint Discovery Plan by AXSOME THERAPEUTICS, INC., ANTECIP BIOVENTURES II LLC.(LIZZA, CHARLES) (Entered: 12/02/2024)PACER Document
Dec 3, 2024ANSWER to Counterclaim by AXSOME THERAPEUTICS, INC., ANTECIP BIOVENTURES II LLC. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 12/03/2024)PACER Document
Dec 5, 2024STIPULATED DISCOVERY CONFIDENTIALITY ORDER. Signed by Magistrate Judge Leda D. Wettre on 12/5/2024. (wh) (Entered: 12/05/2024)PACER Document
Dec 5, 2024PRETRIAL SCHEDULING ORDER. Signed by Magistrate Judge Leda D. Wettre on 12/5/2024. (wh) (Entered: 12/05/2024)PACER Document
Jan 6, 2025Letter from Axsome to the Hon. Leda D. Wettre, U.S.M.J.. (LIZZA, CHARLES) (Entered: 01/06/2025)PACER Document
Jan 7, 2025ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-06489 and 24-10938 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-06489 and that Civil Action No. 24-10938 shall be administratively terminated by the Clerk's Office. To accommodate Plaintiffs' assertion of the '889 patent, the parties shall abide by the herein schedule. The December 5 Pretrial Schedule Order shall otherwise govern the Consolidated Actions (ECF No. 27 in 24-06489). Signed by Magistrate Judge Leda D. Wettre on 1/7/2025. (wh) (Entered: 01/08/2025)PACER Document
Jan 13, 2025Letter from Plaintiffs to the Hon. Leda D. Wettre, U.S.M.J.. (LIZZA, CHARLES) (Entered: 01/13/2025)PACER Document
Jan 15, 2025AMENDED SCHEDULING ORDER. Signed by Magistrate Judge Leda D. Wettre on 1/15/2025. (wh) (Entered: 01/15/2025)PACER Document
May 28, 2024Case Assigned to Judge Michael E. Farbiarz and Magistrate Judge Leda D. Wettre. (ak, )PACER Document
Sep 3, 2024Clerk`s Text Order - The document 15 Application for Clerk's Order to Ext Answer/Proposed Order, submitted by ANTECIP BIOVENTURES II LLC and AXSOME THERAPEUTICS, INC. has been GRANTED. The answer due date has been set for 9/17/2024. (wh)PACER Document
Nov 18, 2024Clerk`s Text Order - The 23 Application for Clerk's Order Extending Time to Answer submitted by AXSOME THERAPEUTICS, INC. and ANTECIP BIOVENTURES II LLC on 11/15/2024 has been GRANTED. The answer due date has been set for 12/3/2024. (wh)PACER Document
Dec 5, 2024Minute Entry for proceedings held before Magistrate Judge Leda D. Wettre: Initial Pretrial Conference held on 12/5/2024. (LM, )PACER Document